The gut microbiota-bile acid axis: A potential therapeutic target for liver fibrosis.

Zhang, Yu-Lin; Li, Zhen-Jiao; Gou, Hong-Zhong; Song, Xiao-Jing; Zhang, Lei

Zhang, Yu-Lin; Li, Zhen-Jiao; Gou, Hong-Zhong; Song, Xiao-Jing; Zhang, Lei.

Afiliación

Zhang YL; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Li ZJ; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Gou HZ; Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China.
Song XJ; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Zhang L; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.

Front Cell Infect Microbiol ; 12: 945368, 2022.

Article en En | MEDLINE | ID: mdl-36189347

Asunto(s)

Microbioma Gastrointestinal; Hepatopatías; Ácidos y Sales Biliares/metabolismo; Disbiosis; Fibrosis; Humanos; Hígado/metabolismo; Cirrosis Hepática/metabolismo; Cirrosis Hepática/terapia

Palabras clave

bile acid; chronic liver disease; gut microbiota; gut microbiotabile acid axis; liver fibrosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microbioma Gastrointestinal / Hepatopatías Límite: Humans Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google